More than 22,000 research scientists from around the world gathered in Chicago for the annual meeting of the American Association for Cancer Research, the largest attendance in the organization’s 111-year history. The conference’s theme, “Driving Innovative Cancer Science to Patient Care,” featured presentations on a wide-range of basic, translational, clinical, and prevention research. Disparities in care were highlighted in a number of presentations and posters, including how to improve cancer treatment and screening in low-income areas, how to narrow inequities to personalized medicine access, and how to find funding for cancer disparities research.
Nearly 70 abstracts from Cleveland were chosen, and more than half of those displayed work from Case Western Reserve University School of Medicine and Case Comprehensive Cancer Center researchers. Among the topics presented in the CWRU/CCCC posters examined a person’s cancer risk linked to a broad range of sources including genes, environment and space travel. . Researchers discussed various approaches for combining medications to kill prostate cancer cells as well as applying bioinformatics to understand phosphorylation patterns in breast cancer.
Stan Gerson, MD, Director of the Case Comprehensive Cancer Center, and other panelists discussed an update on the status of Biden’s Moonshot -- now well-funded through NCI appropriations and supporting NCI Awards to members of Case Comprehensive Cancer Center. Dr. Gerson highlighted how the Center is addressing disparities in a number of ways, including the tobacco cessation intervention led by Monica Webb Hooper, PhD.
At the end of the colloquium, the panelists accepted a challenge from Biden Cancer Initiative President and CEO Greg Simon...to work together on a cancer-related project for the next year and report on it at the AACR Annual Meeting 2019 in Atlanta! View the webcast here.